bioMérieux Continues to Win Numerous Industry Awards for Outstanding Service and Performance

21 July, 2020

bioMérieux has recently been recognized with six IMV ServiceTrak™ Clinical awards for Blood Culture and ID/AST excellence.

DURHAM, N.C. – July 21, 2020 –– bioMérieux, a world leader in the field of in vitro diagnostics and infectious disease management, has recently been recognized with six IMV ServiceTrak™ Clinical Awards for Blood Culture and ID/AST excellence. IMV is part of Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry. IMV ServiceTrak Clinical Awards are presented annually to the manufacturers with the highest satisfied responses in each of three categories, representing the industry best in customer satisfaction, performance, and service.

bioMérieux was proud to win five ServiceTrak Clinical Awards in both 2018 and 2019 and is very honored to receive all six 2020 awards for Blood Culture and ID/AST in recognition of its continued excellence in comprehensive service performance.

This year, laboratory professionals have rated bioMérieux’s technology platforms, system performance, and service to be the best in the following ServiceTrak categories:

Identification & Antibiotic Susceptibility Testing

  • Best Customer Satisfaction
  • Best System Performance
  • Best Service (tied)

​Blood Culture Testing

  • Best Customer Satisfaction
  • Best System Performance
  • Best Service

Additionally, BioFire Diagnostics, bioMérieux’s Global Center of Excellence for Molecular Diagnostics, tied for the ServiceTrak award for Best System Performance under the Molecular Diagnostics category.

“In the middle of a global health crisis, bioMérieux has remained absolutely devoted to maintaining the exceptional experience of our customers―empowering our service teams to go the extra mile to make sure every customer’s needs are met and ensuring that all of our customers are satisfied,” said Dan Biondo, Vice President, Customer Support Operations, AMERICAs, bioMérieux, Inc. 

About bioMérieux

Pioneering Diagnostics

A world leader in the field of in vitro diagnostics for over 50 years, bioMérieux is present in more than 43 countries and serves more than 160 countries with the support of a large network of distributors. In 2018, revenues reached €2.4 billion, with over 90% of international sales.

bioMérieux provides diagnostic solutions (systems, reagents, software, and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

Download the Full Press Release:

Download
Pioneering Diagnostics